Log In
Print this Print this

Champix, Chantix, varenicline

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSelective nicotinic acetylcholine receptor alpha(4)beta(2) partial agonist
Molecular Target Nicotinic acetylcholine receptor alpha(4)beta(2)
Mechanism of ActionNicotinic acetylcholine receptor alpha(4)beta(2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsSmoking cessation; Treat alcohol dependence; Treat smoking addiction in smokers with mild to moderate chronic obstructive pulmonary disease (COPD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today